Author: Himanshu Patni
17 February 2023
Global gene amplification technologies market is expected to register a CAGR of approx. 7% over the period of 2022-2028. Gene amplification technology is a critical component of genomics that is widely used in diagnostics. For various studies, it assists in increasing the number of copies of a gene. Gene amplification is frequently carried out using dendritic polymers, transcription-mediated amplification, polymerase chain reaction to ligase chain reaction, and other methods. The main purpose of gene amplification technology is to compare the gene of the study sample with the genes of other germline or somatic cells. The growing demand for gene amplification technologies can be attributed to the expanding potential of pharmacogenomics is surging investment in genomics by pharmaceutical and biotechnology companies across the globe. For instance, in November 2022, A collaboration between Biotheus, a biotech business based in China that specializes in creating treatments for cancer and autoimmune diseases, and Merck, a well-known scientific and technology company, was recently announced. Biotheus’ turn-around time (TAT) for its cell line characterisation decreased from roughly 60 days to 14 days by using Merck’s Blazar Rodent Panel. Owing to the glaring statistics the increasing applicability of gene amplification and vector engineering across the globe is leading to the growing demand for gene amplification technologies and would contribute to the growth of the market in the forthcoming period as well. Moreover, increased traction owing to their advantages such as no requirement of expensive thermal cyclers, rapid amplification kinetics, and easy multiplication from a single cell fueling the demand for the gene amplification technologies market. Furthermore, technological advancements concerning loop-mediated amplification are expected to drive the market for gene amplification technologies market in the coming years.
For a detailed analysis of the Global Gene Amplification Technologies Market browse through –https://univdatos.com/report/gene-amplification-technologies-market/
Based on the technology, the gene amplification technologies market is segmented into PCR-based amplification, multiple displacement amplification, isothermal DNA amplification, and others. The PCR-based amplification segment accounted for a significant market share and it is estimated that it will grow rapidly during the projected timeframe. PCR technology is widely used in a variety of end-use applications. Furthermore, the widespread use of PCR for COVID-19 detection has resulted in significant revenue generation by this technology.
Based on the application, the market is fragmented into whole genome amplification, exome sequencing, SNP genotyping arrays, array CGH, hybridization, and others. The hybridization segment grabbed a considerable market share, and it is expected to grow at a significant CAGR during the forecast period. In the hybridization process, several multiplication technologies are increasingly being used.
Request for Sample of the report browse through- https://univdatos.com/get-a-free-sample-form-php/?product_id=33379
For a better understanding of the market adoption of gene amplification technologies, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, and Rest of North America), Europe (Germany, France, Italy, Spain, U.K., and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America constitutes a major market for the gene amplification technologies industry owing to the presence of various genetic research programmes in the region, as well as strong research and a commercial base for gene multiplication products and growing funding by numerous government organizations in medical research and its infrastructure.
Some of the major players operating in the market include Qiagen NV; New England Biolabs; Illumina, Inc.; Bio-Rad Laboratories, Inc.; BGI Genomics Co Ltd; Oxford Nanopore Technologies PLC; PerkinElmer, Inc.; Becton Dickinson and Co; Bayer AG; and Agilent Technologies Inc.
Global Gene Amplification Technologies Market Segmentation
Market Insight, by Technology
· PCR-based Amplification
· Multiple Displacement Amplification
· Isothermal DNA Amplification
· Others
Market Insight, by Application
· Whole Genome Amplification
· Exome Sequencing
· SNP Genotyping Arrays
· Array CGH
· Hybridization
· Others
Market Insight, by End-Users
· Hospitals & Clinics
· Pharmaceutical & Biotechnology Companies
· Academic & Research Institutes
· Others
Market Insight, by Region
· North America
o United States
o Canada
o Rest of North America
· Europe
o France
o Germany
o Italy
o Spain
o United Kingdom
o Rest of Europe
· Asia-Pacific
o China
o India
o Australia
o Japan
o Rest of Asia-Pacific
· Rest of World
Top Company Profiles
· Qiagen NV
· New England Biolabs
· Illumina, Inc.
· Bio-Rad Laboratories, Inc.
· BGI Genomics Co Ltd
· Oxford Nanopore Technologies PLC
· PerkinElmer, Inc.
· Becton Dickinson and Co
· Bayer AG
· Agilent Technologies Inc
Get a call back
